Nov 30, 2023 / 02:00PM GMT
Operator
Ladies and gentlemen, welcome to the AB Science conference call. I will leave the floor to Alain Moussy, CEO of AB Science. Please go ahead.
Alain Moussy - AB Science SA - Co-founder & CEO
Thank you, and welcome to everybody from Europe or outside of Europe. We're pleased to hold this conference on a new topic, which is sickle cell disease and the development of Masitinib in sickle cell disease.
With me today to talk about this topic I'm with Olivier Hermine who is co-founder of AB Science and also Professor of Hematology at (inaudible) Necker and a specialist of sickle cell disease. And as you know, I'm the CEO of AB Science. I propose that we walk you through a presentation slide by slide and at the end, as usual, we will open it for your questions. Olivier, I ask you to start the presentation.
Olivier Hermine - AB Science SA - MD
Let me see (inaudible) because I don't see very well the slide. Okay, so slide, please.
Okay. So today, we will call about one disease, which is called a sickle cell
AB Science SA Webcast with Experts in Sickle Cell Disease Transcript
Nov 30, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers